bromocriptine
OBJECTIVES: To assess the efficacy and safety of adjunct bromocriptine (BR)       compared with placebo in the treatment of patients with Parkinson's disease (PD)        who have motor complications.
OBJECTIVES: To assess the efficacy and safety of adjunct  @SUBJECT$  (BR)        @PREDICAT$  with  @OBJECT$  in the treatment of patients with Parkinson's disease (PD)        who have motor complications.